In this can’t-miss episode of Global Market Bulletin TV, iSpecimen (NASDAQ: ISPC) Chief Financial Officer and Interim CEO Tracy Curley sits down with host Leyla Gulen to unveil a major leap forward for the company—the brand new, self-service Open Feasibilities Dashboard on the iSpecimen Marketplace. Curley reveals how this powerful new tool is designed to transform the way scientists identify patient cohorts and locate the biospecimens needed to accelerate medical discovery.
From commercial biotech to academic research institutions, iSpecimen plays a critical matchmaking role—connecting scientists with healthcare providers who have access to patient samples essential for diagnostics, therapeutics, and breakthrough medical technologies. In this exclusive interview, Curley details how the platform’s newest capabilities could meaningfully speed up research timelines and open the door to fresh partnerships across the life sciences sector.
Curley also gives Global Market Bulletin an inside look at iSpecimen’s biggest opportunities ahead, sharing what investors should expect in the next 6 to 12 months as the company aims to grow its marketplace, expand its hospital network, and sharpen its technological edge.
About the Guest: Tracy Curley (CFO & Interim-CEO, iSpecimen)
Tracy Curley brings more than 30 years of high-level experience in public accounting, corporate finance, and executive leadership—expertise that now guides iSpecimen through its next stage of growth. Before joining the company, Tracy built and led major audit practice groups within top accounting firms, specializing in technology, life sciences, and emerging growth companies.
Her career includes prominent roles with KPMG, PwC, Cabot Corporation, Houghton Mifflin, CohnReznick (where she built one of the firm’s fastest-growing practices), Marcum LLP (leading the Northeast high-tech practice), and MFA LLP (working with public emerging-growth tech and life science companies nationwide).
Beyond her executive achievements, Curley’s commitment to community service includes leadership positions with the North Shore Technology Council, the Girl Scouts of Eastern Massachusetts, and Project Green Schools. She holds a Master’s degree in Accounting, a Bachelor’s degree in Business Administration (Accounting concentration) from Kansas State University, and is a licensed CPA in Massachusetts. She also attended the United States Military Academy.
CHECK THIS OUT: Why Nebius (NBIS) Could Outperform CoreWeave & Dominate the $9B AI Infrastructure Market and Is Lucid Group (LCID) Running Out of Cash? $875M Note Deal Raises Alarms.
About iSpecimen (NASDAQ: ISPC)
iSpecimen is reinventing how researchers source human biospecimens. Whether for commercial biotech, academic labs, or nonprofit medical research, acquiring the right specimens at the right time is a critical challenge—and iSpecimen’s Marketplace brings a modern, technology-driven solution.
The platform provides scientists with on-demand access to a vast network of hospitals, labs, biobanks, and healthcare organizations, enabling them to search for patient specimens with precision and efficiency. With its expanding partner ecosystem and new Open Feasibilities Dashboard, iSpecimen is positioning itself as a next-generation infrastructure company for biospecimen procurement and medical discovery.
READ ALSO: Above Food (ABVE) to Issue 1.1 Billion New Shares in Merger and Perpetua Resources (PPTA) Soars 171% as U.S. Approves $1.3B Gold-Antimony Mine.
